Myricetin and methyl eugenol combination enhances the anticancer activity, cell cycle arrest and apoptosis induction of cis-platin against HeLa cervical cancer cell lines

Drug combination therapies are common practice in the treatment of cancer. In this study, we evaluated the anticancer effects of myricetin (MYR), methyl eugenol (MEG) and cisplatin (CP) both separately as well as in combination against cervical cancer (HeLa) cells. To demonstrate whether MYR and MEG...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Int J Clin Exp Pathol
Main Authors: Yi, Jin-Ling, Shi, Song, Shen, Yan-Li, Wang, Ling, Chen, Hai-Yan, Zhu, Jun, Ding, Yan
Format: Artigo
Jezik:Inglês
Izdano: e-Century Publishing Corporation 2015
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4396221/
https://ncbi.nlm.nih.gov/pubmed/25972998
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki